Published in Neuroradiology on February 10, 2010
Hydrophilic polymer embolism and associated vasculopathy of the lung: prevalence in a retrospective autopsy study. Hum Pathol (2014) 1.17
Polymer-induced central nervous system complications following vascular procedures: spectrum of iatrogenic injuries and review of outcomes. Hum Pathol (2016) 0.92
Biocompatibility and cutaneous reactivity of cellulosic polysaccharide film in induced skin wounds in rats. J Mater Sci Mater Med (2015) 0.83
Bioprosthetic mesh of bacterial cellulose for treatment of abdominal muscle aponeurotic defect in rat model. J Mater Sci Mater Med (2016) 0.77
Tissue engineering. Science (1993) 19.65
Drug delivery and targeting. Nature (1998) 6.16
Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation (1996) 3.82
Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res (1991) 2.70
Biodegradable polymer scaffolds for tissue engineering. Biotechnology (N Y) (1994) 2.47
Bioabsorbable polymers: materials technology and surgical applications. Proc Inst Mech Eng H (1998) 1.75
Orthopaedic applications for PLA-PGA biodegradable polymers. Arthroscopy (1998) 1.45
Matrix and bioabsorbable polymeric coils accelerate healing of intracranial aneurysms: long-term experimental study. Stroke (2003) 1.44
Strength retention properties of self-reinforced poly L-lactide (SR-PLLA) sutures compared with polyglyconate (Maxon) and polydioxanone (PDS) sutures. An in vitro study. Biomaterials (2002) 1.09
Immediate and midterm outcomes of patients with cerebral aneurysms treated with Matrix1 and Matrix2 coils: a comparative analysis based on a single-center experience in 250 consecutive cases. Neurosurgery (2008) 1.08
Cellular responses of bioabsorbable polymeric material and Guglielmi detachable coil in experimental aneurysms. Stroke (2002) 1.07
Biocompatibility and resorbability of a polylactic acid membrane for periodontal guided tissue regeneration. Biomaterials (1993) 1.01
Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters. J Pharm Sci (1979) 0.91
Selective endovascular treatment of intracranial aneurysms using micrus microcoils: preliminary results in a series of 78 patients. J Neuroradiol (2002) 0.90
Sustained drug delivery systems. I. The permeability of poly(epsilon-caprolactone), poly(DL-lactic acid), and their copolymers. J Biomed Mater Res (1979) 0.88
Suitability of bioresorbable cages for anterior cervical fusion. J Neurosurg (2003) 0.86
Attempts to map the structure and degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J Biomater Sci Polym Ed (1994) 0.80
Effects of biodegradable self-reinforced polyglycolic acid, poly-DL-lactic acid and stainless-steel spiral stents on uroepithelium after Nd:YAG laser irradiation of the canine prostate. Br J Urol (1997) 0.79
A rabbit model for efficacy evaluation of endovascular coil materials. Surg Neurol (2009) 0.78
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Astrocytes: biology and pathology. Acta Neuropathol (2009) 8.43
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia (2010) 6.23
PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med (2006) 6.02
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA (2012) 5.40
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J Clin Oncol (2013) 3.65
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes. Proc Natl Acad Sci U S A (2004) 3.01
Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance. Cancer Discov (2011) 2.77
Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76
MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke (2004) 2.75
Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol (2008) 2.71
Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol (2006) 2.62
CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke (2011) 2.52
Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA (2011) 2.52
Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J Clin Invest (2003) 2.33
Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol (2002) 2.31
Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci (2004) 2.29
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci Signal (2009) 2.23
Atomistic insights for InAs quantum dot formation on GaAs(001) using STM within a MBE growth chamber. Small (2006) 2.19
Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009). Clin Infect Dis (2012) 2.13
Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells (2009) 2.10
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS (2005) 2.07
Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke (2003) 2.06
Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc Natl Acad Sci U S A (2007) 2.06
Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol (2005) 2.05
In vivo evaluation of electrospun polycaprolactone graft for anterior cruciate ligament engineering. Tissue Eng Part A (2015) 2.04
Unruptured intracranial aneurysms: incidence of rupture and risk factors. Stroke (2008) 2.02
Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke (2006) 2.02
Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia (2009) 1.99
Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci (2009) 1.88
Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis (2011) 1.87
High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A (2011) 1.87
Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol (2010) 1.78
Middle cerebral artery occlusion in the rabbit using selective angiography: application for assessment of thrombolysis. Stroke (2008) 1.76
Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res (2005) 1.73
Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain (2007) 1.73
Habitual physical activity measured by accelerometer and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2012) 1.71
Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol (2009) 1.69
Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke (2002) 1.68
Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am J Pathol (2003) 1.66
Initial clinical experience with matrix detachable coils for the treatment of intracranial aneurysms. J Neurosurg (2006) 1.64
Vascular cognitive impairment. Nat Clin Pract Neurol (2006) 1.64
Accelerated epigenetic aging in Down syndrome. Aging Cell (2015) 1.61
Pathologic findings in retinal pigment epithelial cell implantation for Parkinson disease. Neurology (2009) 1.59
Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc Natl Acad Sci U S A (2011) 1.58
The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng (2006) 1.57
Different features of histopathological subtypes of pediatric focal cortical dysplasia. Ann Neurol (2008) 1.55
Hydrophilic polymer emboli: an under-recognized iatrogenic cause of ischemia and infarct. Mod Pathol (2010) 1.55
Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation. J Biol Chem (2007) 1.55
Electrical stimulation of semicircular canal afferents affects the perception of head orientation. J Neurosci (2013) 1.54
Craniosynostosis in transgenic mice overexpressing Nell-1. J Clin Invest (2002) 1.53
Resolution of pain and complete healing of mandibular osteoradionecrosis using pentoxifylline and tocopherol: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 1.53
Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration. Nat Genet (2012) 1.52
Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering. Biomaterials (2008) 1.48
Anti-prion activity of Brilliant Blue G. PLoS One (2012) 1.48
A new support system using a mobile device (smartphone) for diagnostic image display and treatment of stroke. Stroke (2011) 1.46
Matrix and bioabsorbable polymeric coils accelerate healing of intracranial aneurysms: long-term experimental study. Stroke (2003) 1.44
The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression. Biomaterials (2005) 1.43
Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol (2004) 1.43
Angiographic evidence of aneurysm neck healing following endovascular treatment with bioactive coils. AJNR Am J Neuroradiol (2005) 1.42
A rodent malaria, Plasmodium berghei, is experimentally transmitted to mice by merely probing of infective mosquito, Anopheles stephensi. Parasitol Int (2002) 1.41
Dementia with parkinsonism: what is the diagnosis? Rev Neurol Dis (2004) 1.38
We thank Drs Sluzewski and van Rooij for their critcisms of the ACTIVE Study. AJNR Am J Neuroradiol (2005) 1.38
Intravascular polymer material after coil embolization of a giant cerebral aneurysm. Hum Pathol (2009) 1.38
Initial experience of real-time intraoperative C-arm computed-tomography-guided navigation surgery for pituitary tumors. World Neurosurg (2012) 1.37
Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke. Cerebrovasc Dis (2008) 1.37
Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy. J Acquir Immune Defic Syndr (2007) 1.37
Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng (2006) 1.35
Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord (2004) 1.35
Electroanatomic remodeling of the left stellate ganglion after myocardial infarction. J Am Coll Cardiol (2012) 1.35
Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women. J Acquir Immune Defic Syndr (2008) 1.34
Challenges in the endovascular treatment of giant intracranial aneurysms. Neurosurgery (2006) 1.34
Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin Cancer Res (2002) 1.33
Epileptogenesis in pediatric cortical dysplasia: the dysmature cerebral developmental hypothesis. Epilepsy Behav (2006) 1.32
Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events. Brain Pathol (2010) 1.32
FDG-PET/MRI coregistration and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: a preliminary report. Epilepsia (2006) 1.31
Systemic distribution of West Nile virus infection: postmortem immunohistochemical study of six cases. Brain Pathol (2007) 1.30
Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther (2012) 1.30
The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol (2002) 1.29
Cerebral hemispherectomy in pediatric patients with epilepsy: comparison of three techniques by pathological substrate in 115 patients. J Neurosurg (2004) 1.29
Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes. Am J Pathol (2008) 1.27
A reevaluation of the primary diagnosis of hemangiopericytoma and the clinical importance of differential diagnosis from solitary fibrous tumor of the central nervous system. Clin Neurol Neurosurg (2008) 1.27
Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord (2004) 1.26
Protocol for the examination of specimens from patients with tumors of the brain/spinal cord. Arch Pathol Lab Med (2008) 1.25
Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res (2003) 1.24
The osteoinductive properties of Nell-1 in a rat spinal fusion model. Spine J (2006) 1.24
Contralateral hemimicrencephaly and clinical-pathological correlations in children with hemimegalencephaly. Brain (2005) 1.24
Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia. Ann Neurol (2015) 1.24
A brief prehospital stroke severity scale identifies ischemic stroke patients harboring persisting large arterial occlusions. Stroke (2008) 1.24
In vitro response of MC3T3-E1 pre-osteoblasts within three-dimensional apatite-coated PLGA scaffolds. J Biomed Mater Res B Appl Biomater (2005) 1.23